Hexarelin vs Ipamorelin
Updated November 4, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of Hexarelin and Ipamorelin (also searched as Ipamorelin vs Hexarelin) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
Hexarelin centers on muscle, while Ipamorelin leans toward metabolic. On indexed research, Hexarelin is ahead (Hexarelin: 7 studies, Human evidence; Ipamorelin: 5, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •Hexarelin is strongest for muscle; Ipamorelin for metabolic.
- •Evidence: Hexarelin Human evidence (7 studies) vs Ipamorelin Human evidence (5).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
Ghrelin Agonist | Growth Hormone Release
Hexarelin vs Ipamorelin: side-by-side
| Metric | Hexarelin | Ipamorelin |
|---|---|---|
| Class | Muscle | Muscle |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Human evidence | Human evidence |
| Studies indexed | 7 | 5 |
| Research level | Preclinical | Preclinical |
| Strongest effect | Muscle & body comp | Metabolic & appetite |
| Healing & recovery | 2.0▲ | 2.0▲ |
| Muscle & body comp | 4.0▲ | 3.0 |
| Metabolic & appetite | 3.0▲ | 3.0▲ |
| Neuro & mood | 3.0▲ | 2.0 |
| Sleep & circadian | 1.0▲ | 1.0▲ |
| Inflammation & immune | 2.0▲ | 1.0 |
| Skin & aesthetics | 1.0 | 2.0▲ |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | Hexarelin | Ipamorelin |
|---|---|---|
| Mechanism | GHS-R agonist | Selective GH secretagogue / ghrelin-receptor agonist |
| Route | Subcutaneous injection | Subcutaneous injection |
| Half-life | ~2.5 hours | ~2 h |
| Time to peak | 30 min | — |
| Duration of action | ~6 hours | — |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is Hexarelin?
Hexarelin is a synthetic hexapeptide that belongs to the growth hormone secretagogue (GHS) class, known for its ability to stimulate growth hormone release from the pituitary gland. It has been investigated for its potential therapeutic applications in various conditions, including muscle wasting and age-related decline in growth hormone levels.
Full Hexarelin profile, mechanism & studies →What is Ipamorelin?
Ipamorelin is a synthetic peptide that acts as a selective agonist of the growth hormone secretagogue receptor, primarily stimulating growth hormone release. Its potential therapeutic applications are being explored in various contexts, including weight management and pain modulation.
Full Ipamorelin profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Even | Both ~2.0/5 |
| Muscle | Hexarelin | 4.0/5 effect signal |
| Metabolic | Even | Both ~3.0/5 |
| Neuro | Hexarelin | 3.0/5 effect signal |
| Sleep | Even | Both ~1.0/5 |
| Inflammation | Hexarelin | 2.0/5 effect signal |
| Skin | Ipamorelin | 2.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack Hexarelin and Ipamorelin?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
Hexarelin vs Ipamorelin: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
Hexarelin has 7 approved studies indexed (Human evidence), and Ipamorelin has 5 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is Hexarelin or Ipamorelin better?
It depends on your goal. Hexarelin is strongest for muscle; Ipamorelin for metabolic. Hexarelin has more indexed studies (7). See the goal-by-goal breakdown above.
Is Hexarelin or Ipamorelin better for weight loss?
They score similarly on the metabolic/appetite axis in the community data.
Is Hexarelin or Ipamorelin better for muscle?
Hexarelin leads on the muscle & body-composition axis (4.0/5).
Which has more research, Hexarelin or Ipamorelin?
Hexarelin has 7 approved studies indexed (Human evidence); Ipamorelin has 5 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack Hexarelin and Ipamorelin?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of Hexarelin vs Ipamorelin?
Hexarelin: no community-reported effects logged yet. Ipamorelin: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is Hexarelin or Ipamorelin FDA-approved?
Hexarelin is a research-use compound and is not FDA-approved. Ipamorelin is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Ipamorelin better than Hexarelin?
For metabolic, Ipamorelin has the edge; for muscle, Hexarelin does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Hexarelin and Ipamorelin are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed November 4, 2026.